SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026980
Filing Date
2021-05-12
Accepted
2021-05-12 16:05:57
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20210331.htm   iXBRL 10-Q 1973152
2 EX-31.1 flxn-ex311_8.htm EX-31.1 8788
3 EX-31.2 flxn-ex312_6.htm EX-31.2 8789
4 EX-32.1 flxn-ex321_7.htm EX-32.1 7666
  Complete submission text file 0001564590-21-026980.txt   8664730

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA flxn-20210331.xsd EX-101.SCH 59364
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20210331_cal.xml EX-101.CAL 59193
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20210331_def.xml EX-101.DEF 179704
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20210331_lab.xml EX-101.LAB 478083
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20210331_pre.xml EX-101.PRE 351627
10 EXTRACTED XBRL INSTANCE DOCUMENT flxn-10q_20210331_htm.xml XML 1813447
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 21915069
SIC: 2834 Pharmaceutical Preparations